Michael S. Cuffe - 06 May 2024 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Role
EVP and Chief Clinical Officer
Signature
/s/ Kevin A. Ball, Attorney-in-Fact
Issuer symbol
HCA
Transactions as of
06 May 2024
Net transactions value
-$1,782,683
Form type
4
Filing time
08 May 2024, 17:43:49 UTC
Previous filing
21 Feb 2024
Next filing
13 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction HCA Common Stock Sale $494,400 -1,600 -4.5% $309.00 34,124 06 May 2024 Direct F1
transaction HCA Common Stock Options Exercise $2,594,860 +18,660 +55% $139.06 52,784 07 May 2024 Direct F1
transaction HCA Common Stock Tax liability $3,883,143 -12,349 -23% $314.45 40,435 07 May 2024 Direct F1
transaction HCA Common Stock Gift $0 -4,500 -11% $0.000000 35,935 08 May 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction HCA Stock Appreciation Right Options Exercise $0 -18,660 -100% $0.000000* 0 07 May 2024 Common Stock 18,660 $139.06 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes 2,463.9692 shares acquired under the HCA Holdings, Inc. Employee Stock Purchase Plan.
F2 The stock appreciation rights vested in four equal annual installments beginning on January 30, 2020.